Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10357516 Pathogen-inactivated red blood cell compositions

Patent 10357516 was granted and assigned to Cerus on July, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Cerus

Current Assignee

Cerus

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10357516

Patent Inventor Names

Anna Erickson0

Anne North0

Naheed Mufti0

Date of Patent

July 23, 2019

Patent Application Number

15628510

Date Filed

June 20, 2017

Patent Citations Received

‌

US Patent 12064537 Kits and methods for preparing pathogen-inactivated platelet compositions

‌

US Patent 11235090 Kits and methods for preparing pathogen-inactivated platelet compositions

‌

US Patent 11554185 Systems and methods for treating biological fluids

‌

US Patent 10799533 Plasma compositions and methods of use thereof

‌

US Patent 11883544 System and methods for implementing a biological fluid treatment device

‌

US Patent 12011510 Biological fluid treatment systems

Patent Primary Examiner

‌

Emily A Cordas

Patent abstract

The present invention provides pathogen-inactivated red blood cell compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10357516 Pathogen-inactivated red blood cell compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API